Geron (GERN) Inventory Average (2024 - 2026)
Geron (GERN) posted Inventory Average of $125.0 million for Q1 2026, up 17.86% sequentially from $106.0 million in Q4 2025, and up 163.25% YoY from $47.5 million in Q1 2025.
Geron (GERN) Inventory Average (2024 - 2026) Analysis & Trends
Geron has reported Inventory Average for 3 years, with the latest figure at $125.0 million in Q1 2026.
- Quarterly Inventory Average rose 163.25% year-over-year to $125.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.0 million (up 163.25% YoY) and the FY2025 annual result came in at $77.7 million, changed N/A from the prior year.
- Inventory Average climbed to $125.0 million in Q1 2026 per GERN's latest filing, from $106.0 million in the prior quarter.
- Over five years, Inventory Average peaked at $125.0 million in Q1 2026 and troughed at $10.5 million in Q3 2024.
- A 3-year average of $66.2 million and a median of $62.7 million in 2025 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2025 and 2026: Inventory Average surged 681.44% in 2025, then jumped 163.25% in 2026.
- Over 3 years, Inventory Average stood at $29.5 million in 2024, then soared by 259.44% to $106.0 million in 2025, then gained by 17.86% to $125.0 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $125.0 million, $106.0 million, and $82.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | - |
| 10 | Geron | 1.04 Mn | -299.81 Mn | - | 128.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 128.45 Mn |
| Mar 31, 2026 | 124.96 Mn |
| Dec 31, 2025 | 106.03 Mn |
| Sep 30, 2025 | 82.27 Mn |
| Jun 30, 2025 | 62.67 Mn |
| Mar 31, 2025 | 47.47 Mn |
| Dec 31, 2024 | 29.50 Mn |
| Sep 30, 2024 | 10.53 Mn |